Saturday, May 29, 2010

Image representing Curemark as depicted in Cru...Image via CrunchBase
The MIND Institute at UC Davis is enrolling participants in clinical trials for an autism treatment developed by Curemark LLC, a drug research and development company in Rye, N.Y.
Curemark's treatment is based on research that shows enzyme deficiencies in autistic children cause an inability to digest protein. This affects the production of amino acids, the building blocks of chemicals essential for brain function.
Bookmark and Share
Reblog this post [with Zemanta]